Generation of metastatic variants by transfection of a rat non-metastatic epithelial cell line with genomic DNA from rat prostatic carcinoma cells
1998

Creating Metastatic Variants from Non-Metastatic Prostate Cancer Cells

Sample size: 88 publication Evidence: moderate

Author Information

Author(s): Y Ke, C Beesley, P Smith, R Barraclough, P Rudland, CS Foster

Primary Institution: University of Liverpool

Hypothesis

Can genomic DNA from metastatic prostate cancer cells induce a metastatic phenotype in non-metastatic epithelial cells?

Conclusion

The study successfully generated new metastatic variants of non-metastatic cells by transfecting them with DNA from metastatic prostate cancer cells.

Supporting Evidence

  • Transfection of DNA from low metastatic G cells resulted in 8.7% metastasis in rats.
  • Transfection of DNA from high metastatic AT6.1 cells resulted in 25% metastasis in rats.
  • New cell lines containing fragments of donor prostatic DNA were developed from metastases.

Takeaway

Scientists took DNA from cancer cells that spread and put it into non-spreading cells to see if they could make them spread too, and they did!

Methodology

The study involved transfecting a non-metastatic rat mammary epithelial cell line with fragmented genomic DNA from metastatic prostate cancer cells and then evaluating the resulting cells for metastatic ability in syngeneic rats.

Potential Biases

Potential bias may arise from using only one type of recipient animal for testing the metastatic capability.

Limitations

The study primarily used a single animal model, which may limit the generalizability of the findings.

Participant Demographics

Female Wistar-Furth rats, aged 4-6 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication